Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Instituto Nacional do Câncer. Coordenação de Prevenção e Vigilância. Estimativa 2005: Incidência de Câncer no Brasil. 2004, Rio de Janeiro: INCA, [http://www.inca.gov.br]
Osborne C, Wilson P, Tripathy D: Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications. The Oncologist. 2004, 9: 361-377. 10.1634/theoncologist.9-4-361.
Article
CAS
PubMed
Google Scholar
Shackney SE, Silverman JF: Molecular evolutionary patterns in breast cancer. Adv Anat Pathol. 2003, 10: 278-290. 10.1097/00125480-200309000-00003.
Article
CAS
PubMed
Google Scholar
Beckmann MW, Niederacher D, Schnurch HG, Gusterson BA, Bender HG: Multistep carcinogenesis of breast cancer and tumour heterogeneity. J Mol Med. 1997, 75: 429-439. 10.1007/s001090050128.
Article
CAS
PubMed
Google Scholar
Aubele M, Werner M, Hofler H: Genetic alterations in presumptive precursor lesions of breast carcinomas. Anal Cell Pathol. 2002, 24: 69-76.
Article
CAS
PubMed
PubMed Central
Google Scholar
Driouch K, Dorion-Bonnet F, Briffod M, Champene MH, Longy M, Liderau R: Loss of heterozygosity on chromosome arm 16q in breast cancer metastasis. Genes Chrom Cancer. 1997, 19: 185-191. 10.1002/(SICI)1098-2264(199707)19:3<185::AID-GCC8>3.0.CO;2-U.
Article
CAS
PubMed
Google Scholar
Caligo MA, Polidoro L, Ghimenti C, Campani D, Cecchetti D, Bevilacqua G: A region on the long arm of chromosome 16 is frequently deleted in metastatic node-negative breast cancer. Int J Oncol. 1998, 13: 177-182.
CAS
PubMed
Google Scholar
Cleton-Jansen AM, Callen DF, Seshadri R, Goldup S, McCallum B, Crawford J, Powell JA, Settasatian C, van Beerendonk H, Moerland EW, Smit VTBHM, Harris WH, Millis R, Morgan NV, Barnes D, Mathew CG, Cornelisse CJ: Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions. Cancer Res. 2001, 61: 1171-1177.
CAS
PubMed
Google Scholar
Chalmers J, Aubele M, Hartman E, Braungart E, Werner M: Mapping the chromosome 16 cadherin gene cluster to a minimal deleted region in ductal breast cancer. Cancer Genet Cytogenet. 2001, 126: 39-44. 10.1016/S0165-4608(00)00376-9.
Article
CAS
PubMed
Google Scholar
Overduin M, Harvey TS, Bagby S, Tong KI, Yau P, Takeichi M, Ikura M: Solution structure of the epithelial cadherin domain responsible for selective cell adhesion. Science. 1995, 267: 386-389.
Article
CAS
PubMed
Google Scholar
Hirohashi S: Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol. 1998, 153: 333-339.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hazan RB, Qiao R, Keren R, Badano I, Suyama K: Cadherin switch in tumor progression. Ann N Y Acad Sci. 2004, 1014: 155-163. 10.1196/annals.1294.016.
Article
CAS
PubMed
Google Scholar
Debbies MT, Welch DR: Genetic basis of human breast cancer metastasis. J Mam Gland Biol Neoplasia. 2001, 6: 441-451. 10.1023/A:1014739131690.
Article
Google Scholar
Guilford PJ, Hopkins JB, Grady WM, Markowitz SD, Willis J, Lynch H, Rajput A, Wiesner GL, Lindor NM, Burgart LJ, Toro TT, Lee D, Limacher JM, Shaw DW, Findlay MP, Reeve AE: E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat. 1999, 14: 249-255. 10.1002/(SICI)1098-1004(1999)14:3<249::AID-HUMU8>3.0.CO;2-9.
Article
CAS
PubMed
Google Scholar
Berx G, Cleton-Jansen AM, Strumane K, de LEEuw WJ, Nollet F, van Roy F, Cornellisse C: E-cadherin is inactivated in a majority of invasive lobular breast cancer by truncation mutations throughout its extracellular domain. Oncogene. 1996, 13: 1919-1925.
CAS
PubMed
Google Scholar
Fregen E, Rocca Serra P, Shaposhnikov S, Taine L, Thorsen J, Bepoldin C, Krekling M, Lafon D, Aas KK, El Monéim AA, Johansen H, Longy M, Prydz H, Dorion-Bonnet F: High-resolution integrated map encompassing the breast cancer loss of heterozygosity region on human chromosome 16q22.1. Genomics. 2000, 70: 273-285. 10.1006/geno.2000.6389.
Article
Google Scholar
De Leew WJ, Berx G, Vos KL, Peterse JL, Van de Vijver MJ, Litvinov S, Van Roy F, Cornelisse CJ, Cleton-Jansen AM: Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol. 1997, 183: 404-411. 10.1002/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO;2-9.
Article
Google Scholar
Acs G, Lawton TJ, Rebbeck TR, LiVolsi VA, Zhang PJ: Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol. 2001, 115: 85-98. 10.1309/FDHX-L92R-BATQ-2GE0.
Article
CAS
PubMed
Google Scholar
Wahed A, Connelly J, Reese T: E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma. Ann Diag Pathol. 2002, 6: 349-351. 10.1053/adpa.2002.36660.
Article
Google Scholar
Yang X, Yan L, Davidson NE: DNA methylation in breast cancer. End-Rel Cancer. 2001, 8: 115-127. 10.1677/erc.0.0080115.
Article
CAS
Google Scholar
Szyf M, Paknesham P, Rabbani SA: DNA methylation and breast cancer. Biochem Pharmacol. 2004, 68: 1187-1197. 10.1016/j.bcp.2004.04.030.
Article
CAS
PubMed
Google Scholar
Nass SJ, Herman JG, Gabrielson E, Iversen PW, Parl FF, Davidson NE, Graff JR: Aberrant methylation of the estrogen receptor and E-cadherin 5'CpG islands increases with malignant progression in breast cancer. Cancer Res. 2000, 60: 4346-4348.
CAS
PubMed
Google Scholar
WHO. World Health Organization: International of diseases for oncology. 1990, World Health Organization, Geneva, 2
Google Scholar
Sabin LH, Wittekind CH, Eds: TMN Classification of Malignant Tumours. 1998, John Wiley & Sons, Inc. Publication, 5
Google Scholar
Bloom MJC, Richardson WW: Histologic grading and prognosis in breast cancer. A study of 1709 cases. Br J Cancer. 1957, 11: 358-377.
Article
Google Scholar
Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PLA, Paul CLA: A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA. 1992, 89: 1827-1831. 10.1073/pnas.89.5.1827.
Article
CAS
PubMed
PubMed Central
Google Scholar
Corn PG, Heath RH, Fogt F, Forastiere AA, Herman JG, Wu T: Frequent hypermethylation of the 5' CpG island of E-Cadherin in esophageal adenocarcinomas. Clin Cancer Res. 2001, 7: 2765-2769.
CAS
PubMed
Google Scholar
Sanguinetti CJ, Dias Neto E, Simpson AJ: Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques. 1994, 17: 914-921.
CAS
PubMed
Google Scholar
Debies MT, Welch DR: Genetic basis of human breast cancer metastasis. J Mammary Gland Biol Neoplasia. 2001, 6: 441-451. 10.1023/A:1014739131690.
Article
CAS
PubMed
Google Scholar
Corn PG, Smith BD, Ruckdeschel ES, Douglas D, Baylin SB, Herman JG: E-cadherin expression is silenced by 5'CpG island methylation in acute leukemia. Clin Cancer Res. 2000, 6: 4243-4248.
CAS
PubMed
Google Scholar
Toyooka S, Toyooka KO, Harada K, Miyajima K, Makaria P, Sathyanarayana UG, Yin J, Sato F, Shivapurkar N, Meltzer S, Gazdar AF: Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas. Cancer Res. 2002, 62: 3382-3386.
CAS
PubMed
Google Scholar
Parrela P, Poeta ML, Gallo AP, Prencipe M, Scintu M, Apicella A, Rossielo R, Liguoro G, Seripa D, Gravina C, Rabitti C, Rinaldi M, Nicol T, Tommasi S, Paradiso A, Schittulli F, Altomare V, Fazio VM: Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors. Clin Cancer Res. 2004, 10: 5349-5354. 10.1158/1078-0432.CCR-04-0555.
Article
Google Scholar
Hu XC, Wong IH, Chow LWC: Tumor-derived aberrant methylation in plasma of invasive ductal breast cancer patients: clinical implications. Oncol Rep. 2003, 10: 1811-1815.
CAS
PubMed
Google Scholar
Jerônimo C, Costa I, Martins MC, Monteiro P, Lisboa S, Palmeira C, Henrique R, Teixeira MR, Lopes C: Detection of gene promoter hypermethylation in fine needle washings from breast lesions. Clin Cancer Res. 2003, 9: 3413-3417.
PubMed
Google Scholar
Shinozaki M, Hoon DSB, Giuliano AE, Hansen NM, Wang HJ, Turner R, Taback B: Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis. Clin Cancer Res. 2005, 11: 2156-2162. 10.1158/1078-0432.CCR-04-1810.
Article
CAS
PubMed
Google Scholar
Liu L, Wylie RC, Andrews LG, Tollefsbol TO: Aging, cancer and nutrition: the DNA methylation connection. Mech Ageing Dev. 2003, 124: 989-998. 10.1016/j.mad.2003.08.001.
Article
CAS
PubMed
Google Scholar
De Marzo AM, Marchi VL, Yang ES, Veeraswamy R, Lin X, Nelson WG: Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis. Cancer Res. 1999, 59: 3855-3860.
CAS
PubMed
Google Scholar
Lapidus RG, Ferguson AT, Ottaviano YL, Parl FF, Smith HS, Weitzman SA, Baylin SB, Issa JP, Davidson NE: Methylation of estrogen and progesterone receptor gene 5'CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors. Clin Cancer Res. 1996, 2: 805-810.
CAS
PubMed
Google Scholar
Lapidus RG, Nass SJ, Butash KA, Parl FF, Graff JR, Herman JG, Davidson NE: Mapping of the ER gene CpG island methylation by methylation-specific polymerase chain reaction. Cancer Res. 1998, 58: 2515-2519.
CAS
PubMed
Google Scholar
Ásgeirsson KS, Jónasson JG, Tryggvadóttir L, Ólafdóttir K, Sigurgeirsdóttir JR, Ingvarsson S, Ögmundsdóttir HM: Altered expression of E-cadherin in breast cancer: patterns, mechanisms and clinical significance. Eur J Cancer. 2000, 36: 1098-1106. 10.1016/S0959-8049(00)00062-9.
Article
PubMed
Google Scholar
Esteller M, Fraga MF, Guo M, Garcia-Foncillas J, Hendenfalk I, Godwin AK, Trojan J, Vaurs-Barriéri C, Bignon YJ, Ramus S, Benitez J, Caldes T, Akiyama Y, Yuasa Y, Launonen V, Canal MJ, Rodriguez R, Capella G, Peinado MA, Borg A, Aaltonen LA, Ponder BA, Baylin SB, Herman JG: DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum Mol Genet. 2001, 10: 3001-3007. 10.1093/hmg/10.26.3001.
Article
CAS
PubMed
Google Scholar
Graff JR, Gabrielson E, Fujii H, Baylin SB, Herman JG: Methylation patterns of the E-cadherin 5'CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. The J Biol Chem. 2000, 275: 2727-2732. 10.1074/jbc.275.4.2727.
Article
CAS
PubMed
Google Scholar
Henning G, Lowrick O, Birchmeier W, Behrens J: Mechanisms identified in the transcriptional control of epithelial gene expression. J Biol Chem. 1996, 271: 595-602. 10.1074/jbc.271.1.595.
Article
Google Scholar
Hajra KM, Ji X, Fearon ER: Extinction of E-cadherin expression in breast cancer via dominant repression pathway acting on proximal promoter elements. Oncogene. 1999, 18: 7274-7279. 10.1038/sj.onc.1203336.
Article
CAS
PubMed
Google Scholar
Peinado H, Ballestar E, Esteller M, Cano A: Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell Biol. 2004, 24: 306-311. 10.1128/MCB.24.1.306-319.2004.
Article
CAS
PubMed
PubMed Central
Google Scholar
Herman JC, Graff JR, Myöhänem S, Nelfin BD, Baylin SB: Methylation specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA. 1996, 93: 9821-9826. 10.1073/pnas.93.18.9821.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lombaerts M, Middeldorp JW, van der Weide E, Philipo K, van Wezel T, Smit VTHBM, Cornelisse CJ, Cleton-Jansen AM: Infiltrating leukocytes confound the detection of E-cadherin promoter methylation in tumors. Biochem Biophys Res Commun. 2004, 319: 697-704. 10.1016/j.bbrc.2004.05.041.
Article
CAS
PubMed
Google Scholar
Howard EM, Lau SK, Lyles RH, Birdsong GG, Tadros TS, Umbreit JN, Kochhar R: Correlation and expression of p53, Her-2, vascular endothelial growth factor (VEGF), and e-cadherin in a high risk breast-cancer population. Int J Clin Oncol. 2004, 9: 154-160. 10.1007/s10147-004-0386-4.
Article
CAS
PubMed
Google Scholar
Howard EM, Lau SK, Lyles RH, Birdsong GG, Umbreit JN, Kochhar R: Expression of e-cadherin in high-risk breast cancer. J Cancer Res Clin Oncol. 2005, 131: 14-18. 10.1007/s00432-004-0618-z.
Article
CAS
PubMed
Google Scholar
D'Souza B, Taylor-Papadimitrou J: Over-expression of ERBB2 in human mammary epithelial cells signals inhibition of transcription of the E-CD gene. Proc Natl Acad Sci USA. 1994, 91: 7202-7206. 10.1073/pnas.91.15.7202.
Article
PubMed
PubMed Central
Google Scholar
Droufakou S, Deshmane V, Roylance R, Hanby A, Tomlinson I, Hart IR: Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast. Int J Cancer. 2001, 92: 404-408. 10.1002/ijc.1208.
Article
CAS
PubMed
Google Scholar